Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
22 02 2021
Historique:
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 3 3 2023
Statut: ppublish

Résumé

Human parainfluenza virus type 3 (HPIV-3) is a significant cause of lower respiratory tract infections, with the most severe disease in young infants, immunocompromised individuals, and the elderly. HPIV-3 infections are currently untreatable with licensed therapeutics, and prophylactic and therapeutic options are needed for patients at risk. To complement existing human airway models of HPIV-3 infection and develop an animal model to assess novel intervention strategies, we evaluated infection and transmission of HPIV-3 in ferrets. A well-characterized human clinical isolate (CI) of HPIV-3 engineered to express enhanced green fluorescent protein (rHPIV-3 CI-1-EGFP) was passaged on primary human airway epithelial cells (HAE) or airway organoids (AO) to avoid tissue culture adaptations. rHPIV3 CI-1-EGFP infection was assessed

Identifiants

pubmed: 35164568
doi: 10.1128/mbio.03831-21
pmc: PMC8844927
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0383121

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI114736
Pays : United States

Références

J Infect Dis. 2014 Mar 1;209(5):695-702
pubmed: 24133181
Viral Immunol. 2018 Mar;31(2):133-141
pubmed: 29323621
Dev Biol Stand. 1975;28:414-21
pubmed: 165121
Exp Lung Res. 1981 May;2(2):97-109
pubmed: 6268401
Viruses. 2016 Jun 14;8(6):
pubmed: 27314379
JAMA. 2000 Jan 26;283(4):499-505
pubmed: 10659876
Lancet Glob Health. 2021 Aug;9(8):e1077-e1087
pubmed: 34166626
Vaccine. 2006 Mar 20;24(13):2432-9
pubmed: 16406170
Cell Discov. 2021 Jul 6;7(1):49
pubmed: 34230457
J Virol. 2014 Nov;88(22):13495-502
pubmed: 25210187
J Infect Dis. 2004 Dec 15;190(12):2096-103
pubmed: 15551207
Semin Respir Crit Care Med. 2016 Aug;37(4):538-54
pubmed: 27486735
mSphere. 2021 May 12;6(3):
pubmed: 33980679
Infect Dis Clin North Am. 2019 Jun;33(2):523-544
pubmed: 30940462
mBio. 2016 Mar 15;7(2):e00235
pubmed: 26980833
Virology. 2015 May;479-480:259-70
pubmed: 25816764
Vaccine. 2011 Sep 16;29(40):7042-8
pubmed: 21782874
J Gen Virol. 2020 Oct;101(10):1037-1046
pubmed: 32692644
Vaccine. 2013 Jun 10;31(26):2822-7
pubmed: 23602668
Dev Biol Stand. 1976;33:384-90
pubmed: 182598
Nature. 2015 Oct 1;526(7571):122-5
pubmed: 26416728
J Clin Invest. 2005 Jul;115(7):1688-98
pubmed: 16007245
Clin Microbiol Rev. 2003 Apr;16(2):242-64
pubmed: 12692097
J Clin Invest. 2021 Dec 1;131(23):
pubmed: 34609969
Pediatr Infect Dis J. 1996 Aug;15(8):650-4
pubmed: 8858666
J Virol. 2005 Jan;79(2):1113-24
pubmed: 15613339
Pediatr Infect Dis J. 2003 May;22(5):394-405
pubmed: 12792378
EMBO J. 2019 Feb 15;38(4):
pubmed: 30643021
J Clin Microbiol. 1991 Oct;29(10):2115-9
pubmed: 1658033
PLoS Pathog. 2017 May 8;13(5):e1006371
pubmed: 28481926
Methods Protoc. 2018 Mar 27;1(2):
pubmed: 31164557
Nat Cell Biol. 2017 May;19(5):542-549
pubmed: 28436965
Curr Top Microbiol Immunol. 2009;330:89-110
pubmed: 19203106
Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S11-8
pubmed: 14730265
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Scand J Infect Dis. 2013 Jan;45(1):65-9
pubmed: 22992129
J Neurochem. 2020 Sep;155(2):137-153
pubmed: 31811775
J Pediatr. 2009 May;154(5):694-9
pubmed: 19159905
Nat Commun. 2022 Jan 10;13(1):21
pubmed: 35013229
J Infect Dis. 1973 Dec;128(6):811-66
pubmed: 4358125
J Gen Virol. 2013 Dec;94(Pt 12):2599-2608
pubmed: 23994833
J Infect Dis. 2002 Dec 15;186(12):1713-7
pubmed: 12447755
Viruses. 2018 Jan 02;10(1):
pubmed: 29301313
Vaccine. 2012 Jun 6;30(26):3975-81
pubmed: 22178099
J Infect Dis. 2001 Nov 1;184(9):1093-7
pubmed: 11598830
J Infect Dis. 2007 Mar 15;195(6):773-81
pubmed: 17299706
mBio. 2019 May 7;10(3):
pubmed: 31064833
Proc Soc Exp Biol Med. 1973 Dec;144(3):745-8
pubmed: 4358238
N Engl J Med. 2004 Jan 29;350(5):443-50
pubmed: 14749452
N Engl J Med. 2013 Feb 14;368(7):633-43
pubmed: 23406028
Science. 2021 Mar 26;371(6536):1379-1382
pubmed: 33597220
PLoS One. 2018 Jul 19;13(7):e0200849
pubmed: 30024940
Nat Commun. 2021 Jan 4;12(1):81
pubmed: 33398055
Pediatr Transplant. 2013 Mar;17(2):133-43
pubmed: 23228170
Clin Microbiol Rev. 2017 Apr;30(2):481-502
pubmed: 28179378
Contemp Top Lab Anim Sci. 2002 Jul;41(4):53-7
pubmed: 12109899
J Virol. 1991 Jan;65(1):103-11
pubmed: 1845878
J Infect Dis. 2012 Sep 1;206(5):628-39
pubmed: 22723641
Vaccine. 2000 May 8;18(22):2462-9
pubmed: 10738104
Curr Opin Virol. 2012 Jun;2(3):294-9
pubmed: 22709516
J Infect Dis. 2004 Feb 1;189(3):462-70
pubmed: 14745704
Expert Rev Respir Med. 2011 Aug;5(4):515-26
pubmed: 21859271
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
Am J Med. 1997 Mar 17;102(3A):10-8; discussion 25-6
pubmed: 10868137
Lab Anim (NY). 2013 May;42(5):170-6
pubmed: 23604159
J Virol. 2020 Dec 22;95(2):
pubmed: 33115876
Pediatr Infect Dis J. 2011 Aug;30(8):714-6
pubmed: 21317680
Lancet. 2008 Jan 26;371(9609):329-39
pubmed: 18295000
Blood. 2001 Aug 1;98(3):573-8
pubmed: 11468152
mBio. 2018 Jul 3;9(4):
pubmed: 29970463
PLoS Pathog. 2013;9(5):e1003343
pubmed: 23717200
J Virol. 2009 Jul;83(13):6900-8
pubmed: 19386708
Vaccine. 2013 Nov 19;31(48):5706-12
pubmed: 24103895
mBio. 2013 Oct 22;4(5):e00803-13
pubmed: 24149514
Intervirology. 2019;62(5-6):174-181
pubmed: 31661701
J Virol. 2001 Dec;75(24):12446-51
pubmed: 11711635
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
J Infect Dis. 2005 Apr 1;191(7):1116-22
pubmed: 15747247
Pediatr Clin North Am. 2006 Oct;53(5):929-59, ix-x
pubmed: 17027618
Cells Tissues Organs. 2020;209(4-6):155-164
pubmed: 33486479

Auteurs

Laurine C Rijsbergen (LC)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Katharina S Schmitz (KS)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Lineke Begeman (L)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Jennifer Drew-Bear (J)

Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

Lennert Gommers (L)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Mart M Lamers (MM)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Alexander L Greninger (AL)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Bart L Haagmans (BL)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Matteo Porotto (M)

Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli," Caserta, Italy.

Rik L de Swart (RL)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Anne Moscona (A)

Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Department of Physiology and Cellular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Department of Microbiology and Immunology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

Rory D de Vries (RD)

Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH